Testosterone News and Research

Latest Testosterone News and Research

Mark Cuban's cost-plus drug pricing model offers significant savings to patients

A new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs, according to a study published in the Journal of Urology.

10 Feb 2023

Men with low sexual desire might benefit from kisspeptin

A new study in the journal JAMA Network Open aimed to analyze the mechanistic and clinical effects of the administration of kisspeptin in men with HSDD.

7 Feb 2023

USC researchers identify two promising avenues for developing new ALS treatments

Each year in the U.S., 5,000 patients receive a diagnosis of ALS, an incurable neurodegenerative disease that will likely kill them within two to five years.

7 Feb 2023

Targeting a single enzyme can kill prostate cancer cells

For the first time, researchers have discovered that prostate cancer can be killed by targeting a single enzyme, called PI5P4Kα.

3 Feb 2023

The impact of viral infections on the human endocrine system

Researchers briefly outlined how viral infections trigger endocrinopathies in humans.

3 Feb 2023

New candidate molecule could become an effective non-hormonal male contraceptive

Despite birth control existing for decades, almost none of the options specifically target sperm cells. Researchers are now developing approaches that target testosterone or otherwise interrupt the sperm's ability to fertilize an egg, yet these may not work for everyone.

30 Jan 2023

How salt appetite differs between males and females

A recent Nutrients study reviews differences in salt intake based on sex.

16 Jan 2023

Hormonal therapy may aid in reducing progression of early-stage prostate cancer during active surveillance

For men with early-stage prostate cancer being managed by active surveillance, adding the hormonal agent apalutamide may lower the rate of positive biopsies during follow-up, suggests a preliminary clinical trial in The Journal of Urology, an Official Journal of the American Urological Association.

11 Jan 2023

Insulin-like peptide 3 may be a predictor of hypogonadism and age-associated morbidity in older males

Researchers evaluated whether insulin-like peptide 3 (INSL3) could predict hypogonadism and age-associated morbidity in older males.

3 Jan 2023

Expansion of intermediate cells in prostate cancer correlates with treatment resistance and poor outcomes

Researchers have characterised prostate cancer cell dynamics at a single-cell resolution across the timespan of the disease – from its beginning to the point of androgen independence, where the tumour no longer responds to hormone deprivation therapy.

14 Dec 2022

New drug candidates for male birth control may be on the horizon

For decades, researchers have been working on "male birth control" -; and studies show there is a demand.

30 Nov 2022

Single drug compound may offer a promising new strategy for treating prostate cancer patients

A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells.

23 Nov 2022

Treating long covid is rife with guesswork

Medical equipment is still strewn around the house of Rick Lucas, 62, nearly two years after he came home from the hospital. He picks up a spirometer, a device that measures lung capacity, and takes a deep breath — though not as deep as he'd like.

22 Nov 2022

Researchers are developing calculator that weighs risk and benefit of taking osteoporosis drugs

Osteoporosis is a major, worsening public health problem and bisphosphonates which help restore a healthier balance of bone production and resorption, have been a relatively inexpensive, successful treatment, particularly for those at highest risk for fractures.

16 Nov 2022

Study shows benefits of metastasis-directed therapy without ADT for oligorecurrent prostate cancer

For patients with solitary metastases from prostate cancer, an approach called metastasis-directed therapy (MDT) – focused treatment using surgery or radiation therapy, without androgen deprivation therapy (ADT) – can slow the time to cancer progression, reports a study in The Journal of Urology, an Official Journal of the American Urological Association

10 Nov 2022

More babies, lower risk of endometrial cancer

While many highly industrialized and developed countries report falling or negative population growth rates due to a rapid decrease in the number of babies born each year, a new report adds more strength to the evidence that bearing a baby has a protective effect on the endometrium, the lining of the womb, reducing the risk of endometrial cancer.

8 Nov 2022

Female resilience to cell death could be therapeutically harnessed to improve kidney repair

In the battle of the sexes, women beat men in their ability to recover from kidney injury, but the reasons are not well understood.

8 Nov 2022

Hormone plays vital role in early prediction of age-related morbidity in men

Researchers have discovered the vital role of a hormone, that develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life.

8 Nov 2022

Novel biomarker for the prediction of age-linked disease

Researchers have discovered the vital role of a hormone, that develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life.

8 Nov 2022

Post-‘Roe,’ contraceptive failures carry bigger stakes

Birth control options have improved over the decades. Oral contraceptives are now safer, with fewer side effects. Intrauterine devices can prevent pregnancy 99.6% of the time. But no prescription drug or medical device works flawlessly, and people's use of contraception is inexact.

7 Nov 2022

Testosterone News and Research

Latest Testosterone News and Research

Mark Cuban's cost-plus drug pricing model offers significant savings to patients

Men with low sexual desire might benefit from kisspeptin

USC researchers identify two promising avenues for developing new ALS treatments

Targeting a single enzyme can kill prostate cancer cells

The impact of viral infections on the human endocrine system

New candidate molecule could become an effective non-hormonal male contraceptive

How salt appetite differs between males and females

Hormonal therapy may aid in reducing progression of early-stage prostate cancer during active surveillance

Insulin-like peptide 3 may be a predictor of hypogonadism and age-associated morbidity in older males

Expansion of intermediate cells in prostate cancer correlates with treatment resistance and poor outcomes

New drug candidates for male birth control may be on the horizon

Single drug compound may offer a promising new strategy for treating prostate cancer patients

Treating long covid is rife with guesswork

Researchers are developing calculator that weighs risk and benefit of taking osteoporosis drugs

Study shows benefits of metastasis-directed therapy without ADT for oligorecurrent prostate cancer

More babies, lower risk of endometrial cancer

Female resilience to cell death could be therapeutically harnessed to improve kidney repair

Hormone plays vital role in early prediction of age-related morbidity in men

Novel biomarker for the prediction of age-linked disease

Post-‘Roe,’ contraceptive failures carry bigger stakes

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Testosterone News and Research

Latest Testosterone News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in